Randomized trial shows no difference from sham control ...

Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...

Adjusted analyses associated overestimation with nearly doubled 2-year mortality (aHR 1.98; 95% CI, 1.04-3.77). Differences in advanced-therapy receipt did not explain the mortality signal, suggesting ...

Hospitals continue to face broad-based expense growth driven by a combination of workforce pressures, higher input costs — especially for drugs and supplies — and rising patient volume and acuity. In ...

Data presented at the 2026 Muscular Dystrophy Association meeting could have readthroughs to companies developing therapies for spinal muscular atrophy, Duchenne muscular dystrophy and Becker muscular ...

By capturing details during real-time patient encounters, Oracle Health Clinical AI Agent enables clinicians to spend more time focused on patients, which is critical in the time-sensitive and often ...

CareCloud, Inc. (NASDAQ:CCLD) Q4 2025 Earnings Call Transcript March 12, 2026 CareCloud, Inc. misses on earnings expectations ...

Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure.

The Freedom60 Infusion Pump is designed to support dosing with 50 ml prefilled syringes, while the FreedomEDGE® Infusion System provides a compatible option for 20 mL prefilled syringe formats.

This article is the latest in the Health Affairs Forefront featured topic, Accountable Care for Population Health, featuring analysis and discussion of how to understand, design, support, and measure ...

Representatives of North Carolina hospitals and health insurance plans faced off this week over the lingering dispute over ...

| DelveInsight The surgical robotic systems market is witnessing significant growth, driven by the rising adoption of minimally invasive procedures and the increasing demand for precision and improved ...